Insider Cluster (2 insiders) ·Filed Jun 27, 2026

BDX

BECTON DICKINSON & CO
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $172K total
Actionable Insight • Neutral

The insider sales are too small to convey a meaningful signal. Monitor for any larger insider transactions or changes in corporate events (earnings, M&A, guidance) that could provide directional cues. No immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
BDX ▲ +17.92% at T+60d
NEUTRAL call ✓ call won +17.92% · α vs SPY +13.53% · entry $155.19 → $183.00
Entry anchored
Jun 26, 03:59 PM ET
via exchange tick
T+1d
-2.49%
call -2.49% · α -3.27%
$151.33
settled 3mo ago
T+5d
+0.23%
call +0.23% · α -1.16%
$155.54
settled 3mo ago
T+20d
+0.75%
call +0.75% · α +1.03%
$156.36
settled 2mo ago
T+60d
+17.92%
call +17.92% · α +13.53%
$183.00
settled 10d ago

Price Chart

Loading chart...

Executive Summary

Two BDX executives (EVP Garrison and EVP Feld) sold a combined $172K in shares over a 7-day window. The total value is negligible relative to BDX's $43.6B market cap (0.0004%), making this a routine, non-informative cluster. A separate non-cash grant and tax withholding by another executive are compensation-related and carry no economic signal.

Key Financial Metrics

Direction
selling
Total Value
$172.0K
Insiders
2

Key Facts

  • Garrison Michael David (EVP & Pres Med.Essntl&BioPharm) sold 1,100 shares for $160K on 2026-06-24.
  • Feld Michael (EVP, Chief Revenue Officer) sold 75 shares for $11K on 2026-06-26.
  • Total insider sales of $172K represent ~0.0004% of BDX's $43.6B market cap.
  • A separate non-cash grant of 14,342 shares and tax withholding of 1,935 shares by EVP Muhsin Bilal occurred on 2026-07-01/02 (no economic value).

Financial Impact

Insider sales of $172K are immaterial relative to $43.6B market cap.

Risk Factors

  • Insider sales, while small, could precede broader selling if executives begin to reduce positions more significantly.
  • BDX's historical T+20 performance on prior reports has been negative on average (29% win rate), suggesting the stock may face headwinds regardless of this filing.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
43% bullish (21 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-BDX-1783365593140
9 reports for BDX
Performance horizon
Filters
Rows
Reports for BDX — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$183.40 $182.91▼ −0.27%▲ +1.72%$176.05 (−4.01%)
Jul 22, 2026
10w ago
8-K
NEUTRAL ★ 2/10
$153.16 $187.60▲ +22.49%▲ +19.59%$176.05 (+14.95%)
Jun 27, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$155.19 $156.36▲ +0.75%▲ +1.03%$176.05 (+13.44%)
Jun 27, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$155.19 $156.36▲ +0.75%▲ +1.03%$176.05 (+13.44%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$145.54 $152.90▲ +5.06%▲ +6.18%$176.05 (+20.97%)
May 29, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$146.96 $155.92▲ +6.10%▲ +9.73%$176.05 (+19.80%)
Apr 2, 2026
26w ago
8-K
MIXED ★ 6/10
$155.23 $146.15▼ −5.85%▼ −14.83%$176.05 (+13.42%)
Mar 31, 2026
26w ago
Court Ruling
NEUTRAL ★ 2/10
$157.23 $145.31▼ −7.58%▼ −17.00%$176.05 (+11.97%)
Feb 25, 2026
31w ago
8-K
NEUTRAL ★ 5/10
$176.49 $157.17▼ −10.95%▼ −4.54%$176.05 (−0.25%)
Showing 9 of 9

US Market Status

Market Open — Closes in 3h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 6, 2026